Nvidia Corp vs Health Care Select Sector SPDR Fund — how do they compare? Nvidia Corp trades at $206.9 (market cap $4.92T), while Health Care Select Sector SPDR Fund trades at $160.2. The key difference: Nvidia Corp pays a 0.49% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Nvidia Corp nearer its low. Which is the better fit depends on your goals.
| NVDA | XLV | |
|---|---|---|
Market Cap | $4.92T | — |
Sector | Technology | — |
52-Week High | $235.75 | $164.48 |
52-Week Low | $165.17 | $129.01 |
Enterprise Value | $4.86T | — |
Dividend Yield | 0.49% | — |
Signals from Pluang's Aura AI — not financial advice
Nvidia (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamental performance. Recent earnings consistently beat estimates, with Q1 2026 EPS of $1.87 exceeding the $1.76 forecast. Revenue surged to $130.50B in 2025, driving a net income margin of 62.97%. The stock faces resistance near $210, while support holds at $201.
Outlook remains positive due to AI-driven growth and robust profitability, but risks include peak AI spending concerns and competitive pressures. Analysts project a $325.86 price target, with 75% recommending Buy. Investors should weigh high valuation multiples against sustained earnings momentum.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →